Baird Remains Buyers Of Gilead Before Earnings Release

By: via Benzinga
In a report Thursday morning, analysts at Baird stated that they remain buyers of Gilead Sciences, Inc. (NASDAQ: GILD) before the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.